Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS · 17 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | TBPH | Theravance Biopharma, Inc. | Sale | 6,657 | $16.39 | $109,078.94 | filing |
| 2026-06-15 | TBPH | Theravance Biopharma, Inc. | Sale | 3,329 | $16.39 | $54,562.98 | filing |
| 2026-06-15 | TBPH | Theravance Biopharma, Inc. | Sale | 3,328 | $16.38 | $54,525.29 | filing |
| 2026-05-20 | TBPH | Theravance Biopharma, Inc. | Tax withholding | 5,678 | $16.55 | $93,970.90 | filing |
| 2026-04-01 | TBPH | Theravance Biopharma, Inc. | Award | 18,750 | $0.00 | $0.00 | filing |
| 2026-03-16 | TBPH | Theravance Biopharma, Inc. | Sale | 15,534 | $14.00 | $217,476.00 | filing |
| 2026-03-16 | TBPH | Theravance Biopharma, Inc. | Sale | 7,767 | $13.92 | $108,087.90 | filing |
| 2026-03-16 | TBPH | Theravance Biopharma, Inc. | Sale | 7,766 | $13.92 | $108,073.21 | filing |
| 2026-02-20 | TBPH | Theravance Biopharma, Inc. | Tax withholding | 13,929 | $19.66 | $273,844.14 | filing |
| 2025-12-03 | TBPH | Theravance Biopharma, Inc. | Sale | 15,534 | $18.75 | $291,251.63 | filing |
| 2025-12-03 | TBPH | Theravance Biopharma, Inc. | Sale | 7,767 | $18.75 | $145,630.47 | filing |
| 2025-12-03 | TBPH | Theravance Biopharma, Inc. | Sale | 7,766 | $18.75 | $145,618.71 | filing |
| 2025-11-20 | TBPH | Theravance Biopharma, Inc. | Tax withholding | 9,060 | $17.90 | $162,174.00 | filing |
| 2025-08-20 | TBPH | Theravance Biopharma, Inc. | Tax withholding | 9,096 | $13.39 | $121,795.44 | filing |
| 2025-07-14 | TBPH | Theravance Biopharma, Inc. | Sale | 5,318 | $11.39 | $60,548.09 | filing |
| 2025-07-14 | TBPH | Theravance Biopharma, Inc. | Sale | 4,000 | $11.39 | $45,551.60 | filing |
| 2025-07-14 | TBPH | Theravance Biopharma, Inc. | Sale | 682 | $11.39 | $7,769.82 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.